Montreal-led clinical trial for potential treatment of COVID-19 symptoms
Posted June 28, 2020 11:38 am.
MONTREAL (CITYNEWS) – A clinical trial led by the Montreal Heart Institute is studying the effectiveness of a drug commonly prescribed to treat gout and assessing whether it can be used to treat COVID-19 patients.
The COLCORONA clinical trial will be studying if the drug colchicine can prevent complications in non-hospitalized patients with the virus.
On Saturday, Quebec Premier Francois Legault invited Quebecers to take part in the study.
Researchers are looking for non-hospitalized patients who have been diagnosed with COVID-19 or have the symptoms associated with the virus to take part in the expanded clinical trial.
